These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18548330)

  • 21. The therapeutic dilemma: how to use tadalafil.
    Carosa E; Lombardo F; Martini P; Brandetti F; Jannini EA
    Int J Androl; 2005 Dec; 28 Suppl 2():74-80. PubMed ID: 16236070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
    J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction].
    Zhu XW; Li FY; Fang JJ
    Zhonghua Nan Ke Xue; 2006 May; 12(5):421-3, 427. PubMed ID: 16755872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of tadalafil in the treatment of erectile dysfunction.
    Meuleman EJ
    Expert Opin Pharmacother; 2003 Nov; 4(11):2049-56. PubMed ID: 14596658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence.
    Frajese GV; Pozzi F; Frajese G
    Clin Interv Aging; 2006; 1(4):439-49. PubMed ID: 18046921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study.
    Chen KK; Jiann BP; Lin JS; Lee SS; Huang ST; Wang CJ; Ju-Ton H; Su CK; Costigan TM; Emmick JT
    J Sex Med; 2004 Sep; 1(2):201-8. PubMed ID: 16422975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of male erectile dysfunction following spinal cord injuries using PDE5 inhibitors].
    Srámková T; Sutorý M
    Rozhl Chir; 2008 May; 87(5):250-4. PubMed ID: 18595542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tadalafil for erectile dysfunction: efficacy evaluation].
    Wang X
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):379-83. PubMed ID: 19472916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase 5 inhibitors in male sexual dysfunction.
    Kuthe A
    Curr Opin Urol; 2003 Sep; 13(5):405-10. PubMed ID: 12917517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tadalafil: a new agent for erectile dysfunction.
    Brock GB
    Can J Urol; 2003 Feb; 10 Suppl 1():17-22. PubMed ID: 12625846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil.
    McMahon C
    J Sex Med; 2004 Nov; 1(3):292-300. PubMed ID: 16422959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year experience with tadalafil in the UK: an effective treatment for erectile dysfunction.
    Dinsmore W
    Int J Clin Pract; 2009 Aug; 63(8):1231-6. PubMed ID: 19624790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily Tadalafil: line extension. Beware medicalisation of human existence.
    Prescrire Int; 2008 Aug; 17(96):142. PubMed ID: 19480097
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
    Kloner RA; Jackson G; Hutter AM; Mittleman MA; Chan M; Warner MR; Costigan TM; Vail GM
    Am J Cardiol; 2006 Jun; 97(12):1778-84. PubMed ID: 16765134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.